BioSyent, Inc. is a specialty pharmaceutical company, which engages in the development of pharmaceutical and healthcare products. Its products include Cathejell Jelly, FeraMAX Pd Therapeutic 150, FeraMAX Pd Powder 15, Proktis-M, RepaGyn, and cTIBELLA. The company was founded on April 28, 1947 and is headquartered in Mississauga, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
61
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Biosyent Inc market cap is $141.25M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Biosyent Inc 52 week high is $12.73 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Biosyent Inc 52 week low is $7.66 as of November 18, 2026.
Biosyent Inc stock price today is $12.47.
Biosyent Inc stock price yesterday was $12.49.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Biosyent Inc's P/E ratio is 19.78.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Biosyent Inc P/B ratio is 4.3835.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Biosyent Inc 50-day moving average is $11.87.